Episode Details
Back to EpisodesThe Mastercard Semaglutide Scam? MATCH List | Mystery Fines & How to Fight Back Now | PEP087
Description
“The Mastercard ‘Scam’? MATCH, Mystery Fines, and How to Fight Back”
When a merchant can be fined six figures and MATCH-listed with no reason code and no recourse, something’s broken. In this in-studio episode, hosts Christopher Dryden, Bryce Van De Moere, and Jeremy Stock dissect the growing wave of opaque brand assessments—spotlighting peptide merchants as the latest industry in the crosshairs—and lay out a litigation-first playbook that’s producing real results. We trace how fines flow from brand → sponsor bank → processor → merchant, why “illegal transactions” are cited without specifics, and how silence from support desks drives businesses to the brink.
What’s really happening (and why it matters)
Fines without findings: Banks and processors pass along brand assessments labeled “illegal transactions”—with no identified transaction, product, or victim.
MATCH as a business death sentence: One placement can freeze payouts, block re-boarding, and contaminate every data point tied to the merchant (owners, addresses, phones) for five years.
Pass-the-buck economics: Contracts let banks/ISOs debit merchants immediately, then “close the matter” while offering no explanation.
Category crackdowns: Peptides are a current target, but the pattern repeats across verticals—retroactive penalties and portfolio-wide chill.
Inside the room: the case patterns we’re seeing
No-explanation letters (“matter closed”) and brand notices that say only “illegal transactions.”
Compliant operators (e.g., physician-dispensed therapeutics; research-only SKUs with no dosing) still swept into MATCH.
Small merchants, outsized fines: thousands in monthly volume, five-figure assessments—a mismatch that devastates Main Street.
The playbook that’s moving needles
Skip the endless emails—draft the complaint: A well-pled, ready-to-file complaint forces decision-makers to engage, produce records, and reconsider MATCH placements.
Evidence that persuades banks and brands: COAs/batch IDs, physician oversight records, “research use” controls, age-gating logs, and website/receipt disclosures documented to the week.
Bank-side pressure: Escalate to teams who can dispute assessments upstream; insist on the issuer’s factual basis—or confirm there isn’t one.
Cash-flow protection while you fight: Consider revoking ACH debit authority on fee pulls until facts are produced; negotiate from strength, not after funds are drained.
Pre-boarding prevention: Build front-end addenda and opinion letters that map regulatory compliance to brand policies—so underwriters have cover before any listing occurs.
What you’ll take back to your team
A response framework for brand assessments that arrive with zero specifics
How to document compliance so banks can safely push back
When refund-first de-escalates—and when representment/litigation is the only lever
Contract terms to revisit: data/notice rights, token portability, termination assistance, and dispute timelines that prevent silent offboarding
Bottom line
Mystery fines and MATCH placements shouldn’t be a black box. If you’re an ISO, PayFac, acquirer, or merchant operator, this episode gives you a tactical path: demand specifics, document compliance, escalate intelligently—and be prepared to litigate to get a straight answer. That’s how you protect portfolios, keep good merchants processing, and start pushing this system toward due process.
**Matters discussed are all opinions and do not constitute legal advice. All events or likeness to real people and events is a coincidence.**
Visit Global Legal Law Firm today: https://www.globallegallawfirm.com/podcasts/
A payments podcast of Global Legal Law Firm